Health Check: The Winner Takes It All as US investors back advanced biotech plays
Health Check is renowned biotech journo Tim Boreham’s daily wrap covering morning movers and shakers of note in the ASX Healthcare sector, Monday through Thursday. PYC Therapeutics notes a growing valuation chasm between the data-rich, phase III US …